Prot #RIN-PF-305: A Randomized, Double-Blind, Placebo-Controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Progressive Pulmonary Fibrosis (TETON-PPF)

Project: Research project

Project Details

StatusActive
Effective start/end date6/10/246/10/27

Funding

  • PPD Investigator Services, LLC (Prot #RIN-PF-305 // Prot #RIN-PF-305)
  • United Therapeutics Corporation (Prot #RIN-PF-305 // Prot #RIN-PF-305)